ALT financials
Altimmune (ALT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ALT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $41.00K | – | -$94.49M | -$88.09M | -1.00 |
| 2024 | $20.00K | – | -$103.17M | -$95.06M | -1.34 |
| 2023 | $426.00K | – | -$95.93M | -$88.45M | -1.66 |
| 2022 | -$68.00K | – | -$87.74M | -$84.71M | -1.81 |
| 2021 | $4.41M | – | -$96.91M | -$97.09M | -2.35 |
| 2020 | $8.19M | – | -$54.80M | -$49.04M | -1.91 |
- ALT revenue was $41.00K in fiscal 2025, net income -$88.09M.
Updated 2026-11-13 04:50 UTC